HealthStream Inc. Reports Q1 2024 Financial Results
Ticker: HSTM · Form: 10-Q · Filed: Apr 25, 2024 · CIK: 1095565
| Field | Detail |
|---|---|
| Company | Healthstream Inc (HSTM) |
| Form Type | 10-Q |
| Filed Date | Apr 25, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.00, $0.028, $0.025 |
| Sentiment | mixed |
Sentiment: mixed
Topics: HealthStream, HSTM, 10-Q, Financial Results, Healthcare Technology
TL;DR
<b>HealthStream Inc. reported a 5% increase in Q1 2024 revenue to $20.5 million, but net income decreased to $15.8 million.</b>
AI Summary
HEALTHSTREAM INC (HSTM) filed a Quarterly Report (10-Q) with the SEC on April 25, 2024. Revenue increased to $20.5 million in Q1 2024 from $19.5 million in Q1 2023. Net income was $15.8 million in Q1 2024, down from $16.6 million in Q1 2023. Earnings per share (EPS) were $0.20 in Q1 2024, compared to $0.21 in Q1 2023. The company declared a quarterly dividend of $0.028 per share on April 22, 2024. Total assets were $133.0 million as of March 31, 2024, compared to $127.0 million as of December 31, 2023.
Why It Matters
For investors and stakeholders tracking HEALTHSTREAM INC, this filing contains several important signals. Revenue growth indicates continued demand for HealthStream's subscription and professional services. The decrease in net income, despite revenue growth, warrants further investigation into cost drivers or margin pressures.
Risk Assessment
Risk Level: medium — HEALTHSTREAM INC shows moderate risk based on this filing. The mixed financial results, with revenue growth but declining net income, suggest potential operational inefficiencies or increased costs impacting profitability.
Analyst Insight
Monitor the company's expense management and margin trends in upcoming quarters to understand the drivers behind the net income decrease.
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Subscription Services | 17,100,000 | N/A |
| Professional Services | 3,359,000 | N/A |
Key Numbers
- 20,459,000 — Revenue Q1 2024 (Consolidated Statements of Operations)
- 19,503,000 — Revenue Q1 2023 (Consolidated Statements of Operations)
- 15,750,000 — Net Income Q1 2024 (Consolidated Statements of Operations)
- 16,603,000 — Net Income Q1 2023 (Consolidated Statements of Operations)
- 0.20 — EPS Q1 2024 (Consolidated Statements of Operations)
- 0.028 — Dividend per share (Declared April 22, 2024)
- 132,960,000 — Total Assets March 31, 2024 (Consolidated Balance Sheets)
- 127,009,000 — Total Assets December 31, 2023 (Consolidated Balance Sheets)
Key Players & Entities
- HEALTHSTREAM INC (company) — FILER
- TN (location) — STATE OF INCORPORATION
- 500 11TH AVENUE NORTH (address) — BUSINESS ADDRESS STREET 1
- NASHVILLE (location) — BUSINESS ADDRESS CITY
- 6153013100 (phone) — BUSINESS PHONE
- 2024-03-31 (date) — CONFORMED PERIOD OF REPORT
- 2024-04-25 (date) — FILED AS OF DATE
- 2024-04-22 (date) — Subsequent Event Date
FAQ
When did HEALTHSTREAM INC file this 10-Q?
HEALTHSTREAM INC filed this Quarterly Report (10-Q) with the SEC on April 25, 2024.
What is a 10-Q filing?
A 10-Q is a quarterly financial report with unaudited financials, management discussion, and interim business updates. This particular 10-Q was filed by HEALTHSTREAM INC (HSTM).
Where can I read the original 10-Q filing from HEALTHSTREAM INC?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by HEALTHSTREAM INC.
What are the key takeaways from HEALTHSTREAM INC's 10-Q?
HEALTHSTREAM INC filed this 10-Q on April 25, 2024. Key takeaways: Revenue increased to $20.5 million in Q1 2024 from $19.5 million in Q1 2023.. Net income was $15.8 million in Q1 2024, down from $16.6 million in Q1 2023.. Earnings per share (EPS) were $0.20 in Q1 2024, compared to $0.21 in Q1 2023..
Is HEALTHSTREAM INC a risky investment based on this filing?
Based on this 10-Q, HEALTHSTREAM INC presents a moderate-risk profile. The mixed financial results, with revenue growth but declining net income, suggest potential operational inefficiencies or increased costs impacting profitability.
What should investors do after reading HEALTHSTREAM INC's 10-Q?
Monitor the company's expense management and margin trends in upcoming quarters to understand the drivers behind the net income decrease. The overall sentiment from this filing is mixed.
Risk Factors
- Revenue Concentration [medium — financial]: The company's revenue may be significantly impacted if a substantial portion of its revenue comes from a small number of customers.
Filing Stats: 4,568 words · 18 min read · ~15 pages · Grade level 15.3 · Accepted 2024-04-25 16:13:41
Key Financial Figures
- $0.00 — ch registered Common Stock (Par Value $0.00) HSTM Nasdaq Global Select Market
- $0.028 — ) Dividends declared on common stock ($0.028 per share) — — ( 849 ) — ( 849 ) Sto
- $0.025 — ) Dividends declared on common stock ($0.025 per share) — — ( 767 ) — ( 767 ) Sto
Filing Documents
- hstm20240331_10q.htm (10-Q) — 582KB
- ex_637738.htm (EX-31.1) — 9KB
- ex_637739.htm (EX-31.2) — 9KB
- ex_637740.htm (EX-32.1) — 5KB
- ex_637741.htm (EX-32.2) — 5KB
- ex_654044.htm (EX-99) — 34KB
- 0001437749-24-013221.txt ( ) — 3286KB
- hstm-20240331.xsd (EX-101.SCH) — 32KB
- hstm-20240331_cal.xml (EX-101.CAL) — 35KB
- hstm-20240331_def.xml (EX-101.DEF) — 216KB
- hstm-20240331_lab.xml (EX-101.LAB) — 215KB
- hstm-20240331_pre.xml (EX-101.PRE) — 236KB
- hstm20240331_10q_htm.xml (XML) — 305KB
Financial Statements
Financial Statements 1 Condensed Consolidated Balance Sheets (Unaudited) – March 31, 2024 and December 31, 2023 1 Condensed Consolidated Statements of Income (Unaudited) – Three Months ended March 31, 2024 and 2023 2 Condensed Consolidated Statements of Comprehensive Income (Unaudited) – Three Months ended March 31, 2024 and 2023 3 Condensed Consolidated Statement of Shareholders' Equity (Unaudited) – Three Months ended March 31, 2024 and 2023 4 Condensed Consolidated Statements of Cash Flows (Unaudited) – Three Months ended March 31, 2024 and 2023 5 Notes to Condensed Consolidated Financial Statements (Unaudited) 6 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 12 Item 3.
Quantitative and Qualitative Disclosures about Market Risk
Quantitative and Qualitative Disclosures about Market Risk 18 Item 4.
Controls and Procedures
Controls and Procedures 19 Part II. Other Information 19 Item 1A.
Risk Factors
Risk Factors 19 Item 6. Exhibits 20 SIGNATURE 21 Table of Contents
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements HEALTHSTREAM, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands) March 31, December 31, 2024 2023 ASSETS Current assets: Cash and cash equivalents $ 52,407 $ 40,333 Marketable securities 31,265 30,800 Accounts receivable, net of allowance for doubtful accounts of $ 901 and $ 781 at March 31, 2024 and December 31, 2023, respectively 39,635 34,346 Accounts receivable - unbilled 4,419 4,100 Prepaid royalties, net of amortization 10,960 10,202 Prepaid software maintenance and subscriptions 6,609 7,397 Other prepaid expenses and other current assets 2,094 3,032 Total current assets 147,389 130,210 Property and equipment, net of accumulated depreciation of $ 20,459 and $ 19,503 at March 31, 2024 and December 31, 2023, respectively 12,537 13,005 Capitalized software development, net of accumulated amortization of $ 132,960 and $ 127,009 at March 31, 2024 and December 31, 2023, respectively 41,118 40,643 Operating lease right of use assets, net 19,483 20,114 Goodwill 191,072 191,379 Customer-related intangibles, net of accumulated amortization of $ 59,128 and $ 57,095 at March 31, 2024 and December 31, 2023, respectively 52,511 54,742 Other intangible assets, net of accumulated amortization of $ 15,750 and $ 16,603 at March 31, 2024 and December 31, 2023, respectively 11,939 13,289 Deferred commissions 30,671 31,700 Non-marketable equity investments 4,103 4,134 Other assets 782 726 Total assets $ 511,605 $ 499,942 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 5,313 $ 7,465 Accrued expenses 16,776 22,717 Accrued royalties 5,713 4,556 Deferred revenue 98,268 83,623 Total current liabilities 126,070 118,361 Deferred tax liabilities 16,868 16,132 Deferred revenue, noncurrent 2,076 2,169 Operating lease liability, noncurrent 19,484 20,247 Other long-term liabilities 2,253 2,281 Shareholders' equity: